This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
“Many of these establishments are small-to-medium size operators, with their employees keeping their doors open without access to the support systems in place for other businesses, thus depriving them of potentially lifesaving protections.” ” You can find the full Senate letter here.
From studies that underscore the therapeutic potential of cannabis to political changes that bode well for patients and consumers, there is much to celebrate. Before we close the books on 2018, let’s take a look back at ten of the most significant developments over the past year from ASA’s perspective and consider their impact.
Members of the House and Senate have approved versions of House Bill 364 , which allows qualified patients the option to grow marijuana at home. The measure permits registered patients (or their designated caregivers) to cultivate up to three mature plants in a private location that it not subject to public view. Chris Sununu.
The Changing Landscape of Me dical Marijuana in Massachusetts: What Patients Should Know The Massachusetts medical marijuana program has been a cornerstone of cannabis access since its inception in 2012. MPAA) the states leading voice for patient rights and cannabis policy reform. decrease from peak enrollment.
This week Americans for Safe Access released “ Medical Marijuana Access in the United States: A Patient-Focused Analysis of the Patchwork of State Laws.” The report reviews existing laws and regulations and laws passed in between January 1, 2017 and December 31, 2017, giving states letter grades from “A” to “F.”
Manufacturing and possessing concentrated forms of cannabis are legally protected activities under the state’s medical cannabis access law, according to a unanimous decision issued today by the Arizona Supreme Court. The decision reverses a 2018 ruling by the Arizona Court of Appeals. ounces of hashish.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
Three new laws intended to expand patientaccess to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”
In a statement issued this week, a representative from the Administration acknowledged , “With the exception of businesses that produce or sell hemp and hemp-derived products (Agriculture Improvement Act of 2018, Public Law 115-334), marijuana-related businesses are not eligible for SBA-funded services.”
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
The MS Society has said that thousands of multiple sclerosis patients are being denied access to the approved drug Sativex, which helps improve spasm symptoms in sufferers. Many are finding that despite the treatment being approved, they are being denied access in their area.”.
Since 2018, voters have attempted to pass adult use but have failed. Mary Schneider (D) cleared the House in an 86-6 vote this March, allowing terminally ill patients to use proof of their admittance in hospice care in lieu of a doctor’s written recommendation to register as a medical cannabis patient. Doug Burgum (R).
Virginia’s medical cannabis program , which currently affords patients, caregivers, and processors only an affirmative defense, will also see potential for robust expansion to improve patientaccess. “Virginia spent over $100M in 2018 enforcing prohibition, which flies in the face of public opinion.
In nursing school, I wrote my dissertation on the role of the nurse when caring for patients using cannabis therapeutically, knowing that nurses are often the first healthcare professional to whom patients disclose their cannabis use. I remain in awe of these patients to this day.
State lawmakers have approved a series of bills reducing penalties for marijuana possession offenses and strengthening and expanding legal protections for medical cannabis patients. Senate Bill 406 expands medical cannabis access and provides important new patient protections. The measures now await action from Democratic Gov.
Under the law, which voters approved in 2018, regulators must license a minimum of 24 dispensaries in each of Missouri’s eight congressional districts. Regulators have already registered 27,000 patients to participate in the cannabis access program. Licensed dispensaries are expected to be operational by this spring.
Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. Of course, patients need product and product costs money.
Adapted from The Medicalization of Marijuana: Legitimacy, Stigma, and the Patient Experience (Routledge, 2019) by Michelle Newhart and William Dolphin. In January 2018, “medical marijuana” appeared roughly 1,750,000 times to a mere 567,000 hits for “medical cannabis.” comes with the territory.
The questions : Initiative 65 (citizen initiated) : Should Mississippi allow qualified patients with debilitating medical conditions, as certified by Mississippi licensed physicians, to use medical marijuana? Under this proposal, patients would be prohibited from smoking whole-plant marijuana. ounces of cannabis per 14-day time period.
Patients diagnosed with chronic pain and other debilitating conditions typically reduce, or in some cases, eliminate their use of opioids following their enrollment in state-sanctioned medical cannabis access programs. Several peer-reviewed studies now document this trend. percent versus 44.8 percent versus 3.4
Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. Then, in 2017 and 2018, Virginia finally made some moves to establish its own medical marijuana industry. JM Pedini | Photo by Adam Ewing.
However, the number of states that will authorize qualified patients from out-of-state medical marijuana programs is still relatively small. . That doesn’t mean you can’t access a green state’s medical marijuana programs, though. Let’s take a look at which US states that have a reciprocity program for guests that are cannabis patients.
It was referred to the Senate Judiciary Committee on 3/22/2018 and is still stuck in committee. The bill was voted out of committee on 11/26/2018 and is now on its second floor reading and waiting for a scheduled vote. 10 would expand patients’ access to medical cannabis through several means. Companion bills S.
Forbes report… A young boy and his single mother are in the midst of a 1,000-mile walk across the United Kingdom, a journey they are making to raise awareness and funds to provide medicinal cannabis to chronically ill patients. The Caldwells have three primary goals in mind as they journey across the U.K. The Boy Who Changed The Law.
Shanita Penny, President of the Minority Cannabis Business Association (MCBA) said , “The Ending Federal Marijuana Prohibition Act of 2019 removes a roadblock impeding criminal justice reform, patient and consumer access, research and innovation.
It was approved in 2018 as a Schedule V substance, which is to say, a substance with a low potential for abuse considered not to be dangerous. Though Dravet Syndrome typically manifests itself in the first year of life, Epidiolex is only approved for treating patients two years of age and older. . Epidiolex has a complex history.
New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).
The accessibility of medical marijuana is an important issue for MMJ patients all over the country. In Oklahoma, accessibility has never been a problem since MMJ became legal in 2018. Since medical marijuana was legalized in Oklahoma in summer 2018, the OK MMJ industry has gone from strength to strength.
The Decline of Medical Marijuana in Massachusetts: What It Means for Patients In recent years, Massachusetts, once a pioneer in cannabis reform, has seen its medical marijuana program gradually overshadowed by the booming recreational market. Let’s explore how this shift occurred and its implications for patients.
By the end of 2018 there were almost 60,000 patients, and nearly $100 million had been taken in the first year of sales. It is projected that there will soon be over 200,000 registered medical marijuana patients in Maryland. Every Maryland Dispensary That MMJ Patients Need To Know. Let’s dive in! Is MMJ Legal In Maryland?
The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.
16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. The Missouri Department of Health and Senior Services (DHSS) issued 56,448 new patient licenses and 12,062 renewed patient licenses between Dec. Psychiatric disorders accounted for 11,914 patients.
Senior Associate, David Hardstaff and Partner, John Binns of BCL Solicitors LLP , explore the UK’s doomed Medical Cannabis (Access) Bill. For UK-based patients struggling to access much needed cannabis-based medicines, it has been difficult to be heard over the white noise of the daily news cycle. Barriers to patientaccess.
Sapphire Medical Clinics has become the first medical cannabis access clinic in the UK to be approved for video consultations. The approval from the Care Quality Commission (CQC) is expected to help improve patientaccess to medical cannabis products across the UK. More at [link].
Instead, he wanted everyone to have access to it. Most patients say it tastes terrible – imagine the most bitter, plant-like flavor you can think of, and you’re getting close. Not just for Rick, but for all the patients who depended on him? In 2018, life threw Rick another curveball when he suffered a stroke.
A United Kingdom police chief proposed a novel idea this January: Allow drug-dependent inmates access to free cannabis to help them overcome opioid addiction. This creates a situation where state detention facilities — even where cannabis is legal — do not allow inmates access to medical cannabis because it violates federal law.
Qualifying medical patients can purchase and consume medicinal CBD oil that contains less than 0.9% It expanded qualifying conditions and allowed patients to access select THC products through state-licensed dispensaries. Since the passage of the 2018 Farm Bill, hemp-derived CBD is federally legal across all 50 states.
The two-and-one-half year wait is finally over for medical cannabis patients living on the Big Island of Hawaii, more accurately known as Hawai‘i Island. only the first 30 patients in line were welcomed inside. Patients were also able to purchase tinctures and edibles. When the doors opened at 11 a.m., HISTORY MADE!!!
BCL Senior Associate, David Hardstaff and Partner, John Binns write for Open Access Government exploring the UK’s doomed Medical Cannabis (Access) Bill. For UK-based patients struggling to access much needed cannabis-based medicines, it has been difficult to be heard over the white noise of the daily news cycle.
Oklahoma has embraced the medical marijuana (MMJ) movement with open arms — positively impacting patients across the state. Let’s unlock the relief and potential that MMJ offers to qualifying patients. Once your application is approved, you will receive a patient identification card.
As of June 2022, there is no way for medical patients to obtain a cannabis prescription or get medication. Patients can only be prescribed manufactured cannabis products including: pills, capsules, suppositories, tinctures, gels, oil, cream, patches, or nebulizers. CBD is legal in Alabama under the 2018 federal farm bill.
According to the 2021 State of Mental Health in America by nonprofit organization Mental Health America (MHA), 19% of adults experienced a mental illness between 2017 and 2018, an increase of 1.5 One of the major obstacles many with a mental illness face is access to and affordability of treatment and resources. Anorexia, PTSD.
Right-to-try aims to allow patients who have been diagnosed with life-threatening diseases or conditions who have tried all approved treatment options and who are unable to participate in a clinical trial to access certain unapproved treatments. Right-to-try permits those patients to have access to investigational drugs.
After two years of waiting, medical marijuana patients in North Dakota’s largest city will finally have safe, reliable access to medication. Only 120 medical marijuana cards have been issued to patients at this time. Acreage Holdings was awarded two North Dakota dispensary licenses in September of 2018. Acreage Holdings.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content